Intravenous Infusions (XGHA:IIL) Insider Ownership: 0.00 % (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:IIL Intravenous Infusions Ltd XGHA:IIL
3 GF Score
Price GHS0.46
View Full Analysis

What is Intravenous Infusions Insider Ownership?

Intravenous Infusions XGHA:IIL +6.98% 3 Insider Ownership is 0.00 % as of Aug. 15, 2026. GuruFocus rates XGHA:IIL with a GF Score™ of 3/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Intravenous Infusions's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Intravenous Infusions's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Intravenous Infusions's Float Percentage Of Total Shares Outstanding is N/A.

Intravenous Infusions Insider Ownership Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Insider Ownership Chart

Intravenous Infusions Annual Data
Trend
Insider Ownership

Intravenous Infusions Semi-Annual Data
Insider Ownership
XGHA:IIL
3GF Score
Intravenous Infusions Ltd XGHA:IIL
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intravenous Infusions Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Intravenous Infusions (XGHA:IIL) has a Insider Ownership of 0.00 % as of Aug. 15, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Insider Ownership too high?
Intravenous Infusions' current Insider Ownership is 0.00 %. Overall, Intravenous Infusions has a GF Score™ of 3/100, reflecting its overall financial health beyond just this single metric.
How does Intravenous Infusions' Insider Ownership compare to PTLF and PCYN?
Intravenous Infusions' Insider Ownership of 0.00 % can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Drug Manufacturers company?
A good Insider Ownership depends on the Drug Manufacturers industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Insider Ownership of 0.00 %. The current Insider Ownership is 0.00 %. Intravenous Infusions' overall GF Score™ is 3/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Insider Ownership is 0.00 % as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
3GF Score

Get the complete analysis for XGHA:IIL

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.46
Price